Expert Perspectives in Medicine

Expert Perspectives in Medicine The publication is published by Engage Health Media Group, which has enlisted well respected, recognized, and prominent thought leaders to its Advisory Board.

Expert Perspectives in Medicine is a premier next generation and customized publication featuring highly prominent thought leaders providing their expert opinions, insights, and commentary on the leading topics and issues in specific disease state medicine. The publication will feature a relevant scientific platform authored by experts and delivered to targeted healthcare providers.

11/23/2025
Early Happy Birthday Dad. Love and miss you ❣️
10/10/2025

Early Happy Birthday Dad. Love and miss you ❣️

10/10/2025

Helichrysum is a highly aromatic herb praised in aromatherapy most notably for bruises and wound healing. Helichrysum can assist with circulatory ailments such as varicose veins, bruises, and broken capillaries. Promote healthy skin Improve healing in bruises and wounds Reduce pain in joints Promote...

01/27/2017

'Screen and treat' policies to preventing type 2 diabetes are unlikely to have substantial impact on this growing epidemic, concludes a study published by The BMJ.

01/27/2017

In addition to achieving good glycemic control, diabetes care management aims to improve the quality of life (QOL) in patients. Treatment-associated difficulties and side effects frequently cause deterioration in QOL. Liraglutide, a GLP-1 receptor agonist, is a novel injection drug that promotes ins...

01/27/2017

Click on the article title to read more.

01/27/2017
01/27/2017

Several GLP-1 receptor agonists are currently available for treatment of type 2 diabetic patients. Based on their pharmacokinetic/pharmacodynamic profile, these drugs are classified as short-acting GLP-1 receptor agonists (exenatide and lixisenatide) or long-acting GLP-1 receptor agonists (exenatide...

01/27/2017

A weekly dipeptidyl peptidase-4 (DPP-4) inhibitor was just as effective at controlling type 2 diabetic patients' blood sugar as a daily DPP-4 inhibitor in a recent randomized clinical trial.

01/27/2017

Click on the article title to read more.

Address

New Hope, PA
18938

Website

Alerts

Be the first to know and let us send you an email when Expert Perspectives in Medicine posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category